Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adalimumab for Inactive Non-infectious Intermediate-, Posterior-, or Pan-uveitis (Phase 3)
2009-016008-22Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- May 2010
- Modality
- Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
Phase 3 trial of adalimumab in Intermediate Uveitis (IU) and uveitis, sponsored by Abbott Laboratories. Primary endpoint: Time to treatment failure. Started May 2010; status: completed.
02
Drugs
03
Conditions
Intermediate Uveitis (IU)uveitis
Beyond the preview
Go deeper on 2009-016008-22.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016008-22.